Category survey

The Netherlands Brain Bank (VUMC) Biobanks Netherlands Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Netherlands Brain Bank (NIN) Biobanks Netherlands Neurodegenerative disease in general 2016    

Multiple Sclerosis Society & Parkinson’s UK Tissue Bank Biobanks United Kingdom Parkinson’s disease & PD-related disorders 2016    

University of Debrecen Faculty of Medicine Brain Bank Biobanks Hungary Neurodegenerative disease in general 2016    

DNA and cell bank-ICM Biobanks France Neurodegenerative disease in general 2016    

Brains for Dementia Research Biobanks United Kingdom Alzheimer’s disease & other dementias 2016    

CRB-HCL : NeuroBiotec Biobanks France Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

CRB-HCL : CardioBioTec – Tissue Bank Biobanks France Alzheimer’s disease & other dementias|Neurodegenerative disease in general|Prion disease 2016    

NIH Biobank and King College UK Biobanks Canada Alzheimer’s disease & other dementias 2016    

Irish ALS DNA BANK Biobanks Ireland Motor neurone diseases 2016    

Dementia biobank Biobanks Sweden Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

AIBL Biobank Biobanks Australia Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

CRB HUEP-UPMC Biobanks France 2016    

CRB-CHU Montpellier Biobanks France 2016    

DNA Bank (University of Ostrava) Biobanks Czech Republic Alzheimer’s disease & other dementias 2016    

Pre-MCI Kohort, at-risk for AD kohort – planned- DZNE; University of Bonn Biobanks Germany Alzheimer’s disease & other dementias 2016    

NSW Brain Tissue Resource Centre Biobanks Australia Neurodegenerative disease in general 2016    

CIEN Foundation Tissue Bank for Neurological Research (BT-CIIN) Biobanks Spain Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

Sydney Brain Bank Biobanks Australia 2016    

Victorian Brain Bank Biobanks Australia Neurodegenerative disease in general 2016    

HUNT Biobank Biobanks Norway Alzheimer’s disease & other dementias|Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Irish Network for Biomarkers in Neurodegeneration (IN-BIND) Biobanks Ireland Alzheimer’s disease & other dementias 2016    

Parkinson’s disease biosamples Biobanks Ireland Parkinson’s disease & PD-related disorders 2016    

KND (DCN), E1, Competence network dementia, Early- and differential diagnosis, genetics Biobanks Germany Alzheimer’s disease & other dementias 2016    

KND (DCN), E3, competence networt dementia, epidemiology Biobanks Germany Alzheimer’s disease & other dementias 2016    

Memory Clinic, KBFZ, University of Bonn Biobanks Germany Alzheimer’s disease & other dementias 2016    

Biological samples in patients with human prion diseases Biobanks Germany Prion disease 2016    

biological samples in patients with Alzheimer’s diseases and other dementia Biobanks Germany Alzheimer’s disease & other dementias 2016    

Genbank Parkinson’s Disease Germany – GEPARD Biobanks Germany Parkinson’s disease & PD-related disorders 2016    

LIFE Biobank Biobanks Germany Alzheimer’s disease & other dementias 2016    

The development of a comprehensive medicines management approach for persons with dementia Investments < €500k United Kingdom 2016    

A feasibility study of facilitated reminiscence for people with dementia Investments < €500k United Kingdom 2016    

The evaluation of a Healthcare Passport to improve quality of care and communication for people living with dementia (EQulP) Investments < €500k United Kingdom 2016    

Risk Communication in Dementia Care Investments < €500k United Kingdom 2016    

Modified intrinsic excitability in transgenic mouse models of progressive beta-amyloidopathy Investments < €500k United Kingdom 2016    

MICA- Evaluation of AZD1080 (GSK-3 inhibitor) in a preclinical mouse model of motor neuron disease (MND) Investments < €500k United Kingdom 2016    

Analysing the cell biology of the Parkinson’s Disease-linked missense mutation in the retromer VPS35 subunit. Investments < €500k United Kingdom 2016    

Amyotrophic Lateral Sclerosis and the DNA Damage Response Investments < €500k United Kingdom 2016    

Investigation of the mechanism by which huntingtin fragments are produced and their pathogenic relevance to Huntington’s disease Investments < €500k United Kingdom 2016    

Molecular mechanisms of TDP-43 mediated neurodegeneration Investments < €500k United Kingdom 2016    

Targeting glucocerebrosidase for disease-modifying treatments in Parkinson’s disease Investments < €500k United Kingdom 2016    

WNT signaling: biomarker and target evaluation in Alzheimer’s disease Investments < €500k United Kingdom 2016    

The importance of precision: a model for movement and movement disorders. Investments < €500k United Kingdom 2016    

Direct current stimulation and rehabilitation of comprehension deficits in stroke aphasia Investments < €500k United Kingdom 2016    

Evaluating the effects of a virtual communication environment for people with aphasia Investments < €500k United Kingdom 2016    

Creative Conversations: An exploratory study of an arts in health apporach to embedding person-centered care and improving communication between care staff and people living with dementia Investments < €500k United Kingdom 2016    

REACT Project: an investigation of the active components of a specialist home treatment intervention to proevent hospital admission of people with dementia in crisis in the community Investments < €500k United Kingdom 2016    

Cognitive rehabilitation for Parkinsons disease dementia: a pilot Investments < €500k United Kingdom 2016    

Exploring the economics of hospital care for people with dementia Investments < €500k United Kingdom 2016    

EEG Neurofeedback as a treatment method for Parkinson Disease. Investments < €500k United Kingdom 2016